Antonio Marra, DO
Emergency Medicine · Neptune, NJNPI 1508816281
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $33,173 of the $36,580 with a category attached, or 90.7%. Novartis accounts for 98.5% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2021 at $17,156 and has fallen 99.8% since, to $33 in 2025. Among emergency medicine clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 78 payments — averaging $468.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$36K
- Johnson & Johnson$149
- Bioxcel Therapeutics, Inc.$124
- AstraZeneca$109
- Ferring Pharmaceuticals Inc.$106
- Braeburn Inc.$33
- plus $26 from 1 others
What the payments were for
- Consulting fees$33,17391%
- Speaking & faculty fees$2,8508%
- Travel & lodging$100%
- Food & beverage$5481%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 68 | $36,032 |
| Johnson & Johnson | 3 | $149 |
| Bioxcel Therapeutics, Inc. | 2 | $124 |
| AstraZeneca | 1 | $109 |
| Ferring Pharmaceuticals Inc. | 1 | $106 |
| Braeburn Inc. | 2 | $33 |
| Regeneron | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$36,580 in reported general payments places this provider in the 95th percentile of 1,505 emergency medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 20 | $166 |
| Naproxen | 13 | $65 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $61 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Neptune
- Atul PasrichaNeptune$3K
- Gregg MojaresNeptune$2K
- Michael GouldSomerville$2.8M
- Kenneth MinettParsippany$797K
- Marc MilanoBerkeley Heights$392K
- Gerardo ChiricoloToms River$161K
- Hardik SoniDenville$159K
- Lindsay van PeltPompton Plains$146K
- Joseph TestaWayne$100K
- Chinwe OgedegbeEast Orange$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.